Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens, C Teunissen… - Alzheimer's & …, 2019 - Elsevier
Introduction We investigated relations between amyloid-β (Aβ) status, apolipoprotein E
(APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …
被引用次数：106 相关文章

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - … , Ill.]-Orlando, Fla …, 2019 - repository.uantwerpen.be
Introduction We investigated relations between amyloid-β (Aβ) status, apolipoprotein E
(APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - … & dementia: the …, 2019 - research.regionh.dk
INTRODUCTION: We investigated relations between amyloid-β (Aβ) status, apolipoprotein E
(APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - … & Dementia: Journal …, 2019 - diva-portal.org
METHODS: We included 770 individuals with normal cognition, mild cognitive impairment,
and Alzheimer's disease (AD)-type dementia from the EMIF-AD Multimodal Biomarker …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, S Lovestone - Alzheimer's and Dementia, 2019 - ora.ox.ac.uk
Introduction We investigated relations between amyloid-β (Aβ) status, apolipoprotein E
(APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …

[引用][C] Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - Alzheimer's & Dementia …, 2019 - hal.science
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial
activation across the clinical Alzheimer's disease spectrum - Archive ouverte HAL Accéder …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - Alzheimer's & …, 2019 - cris.maastrichtuniversity.nl
Introduction: We investigated relations between amyloid-beta (A beta) status, apolipoprotein
E (APOE) e4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.

I Bos, S Vos, F Verhey, P Scheltens… - … & dementia: the …, 2019 - folia.unifr.ch
METHODS We included 770 individuals with normal cognition, mild cognitive impairment,
and Alzheimer's disease (AD)-type dementia from the EMIF-AD Multimodal Biomarker …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - Alzheimer's & …, 2019 - discovery.ucl.ac.uk
Introduction We investigated relations between amyloid-β (Aβ) status, apolipoprotein E
(APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

I Bos, S Vos, F Verhey, P Scheltens… - Alzheimer's & …, 2019 - Wiley Online Library
Introduction We investigated relations between amyloid‐β (Aβ) status, apolipoprotein E
(APOE) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng) …